Abstract
COS have many biological activities, and have been widely used as a health food. Molecular size is considered as a key parameter for COS’ activities. However, many criteria are used practically, and true qualities of COS from different producers may not be always comparable. This can partly explain the disagreement in COS’ functional researches, as resulting in COS, even with astonish effects, have not been further developed as a drug for tumor patients. As anti-tumor activities have been studied based on DP in pharmacological researches, we employed MALDI-TOF-MS to monitor fine structure, including DP, in COS’ preparation and comparison. Then one of the COS products was analyzed with the composition of DP 5–12, mainly 7–10. Moreover, that COS’ product contains well-distributed acetyl groups, while typical Commercial COS sample nearly contains no acetyl groups. As fresh precise parameters, the DP and the number of acetyl groups matching with special DP can be introduced in COS’ further study on structure–activity relationships (SARs) as a new drug.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.